MedPage Today) — BERLIN — Patients with cisplatin-ineligible bladder cancer had huge reductions in clinical events and cancer death when treated with a novel combination therapy before and after surgery, according to a randomized trial reported…
‘Remarkable’ Survival Outcomes in Cisplatin-Ineligible Bladder Cancer

Leave a Comment Leave a Comment
